NGS Laboratory Operations Conference

January, 2020 | San Diego, CA

NGS Laboratory Operations Conference
January, 2020 | San Diego, CA

Request Invite

WE GUARANTEE 100% PRIVACY, YOUR INFORMATION WILL NOT BE SHARED

“I thought the conference was excellent!  Having a conference tailored to one discipline made each panel and contact relevant.”

Director, Compliance & Legal Affairs
Orexigen

“Great insight to hear payer perspective in contracting and account management and the changing healthcare landscape.”

Channel Liaison
Biogen

“It was definitely an excellent well-rounded opportunity to meet new people, get new ideas, and get an in-depth education on what’s to come with the FDA collaborations.”

Quality Engineer
Centurion Medical Products

“It was very well organized event and high quality, the fact to have an IVD track was also interesting. Thanks, I will recommend the Q1 event!”

Regulatory Affairs – EMEA Regional Head
BIOMERIEUX

“The organization and support staff were fantastic! I’m looking forward to next year.”

Global Business Project Lead
Genentech

About the Conference:

Technology supporting Next Generation Sequencing for diagnostic tests continues to rapidly evolve, supporting faster and more accurate results, but as with many bleeding edge technologies, at times lack clear regulatory guidance as well as industry harmonization on processes and quality controls. In order to deliver test results of the highest accuracy, laboratory operations leadership must establish robust procedures and operating frameworks, spanning both wet and dry lab operations while at the same time balancing the business objectives of the laboratory. From improving quality, productivity and efficiency to analysis of the impact of current and future regulatory action on FDA and CMS regulated tests, this meeting will provide executives with an unrivaled opportunity for industry collaboration.

Core Topics to be Addressed:

  • Trends and opportunities in NGS quality control management
  • Aligning laboratory and business objectives in NGS operations
  • Reduction in turnaround time for NGS data analysis & reporting
  • CMS & FDA regulation impacting varied NGS tests & systems
  • Considerations in the future of sequencing & impact on operations

Core Topics to be Addressed:

  • Strategic Alignment for Companion Diagnostics
  • Post-Market Surveillance & Quality Concerns
  • Implementation of European IVD Regulation (IVDR)
  • Regulatory Changes for Varied Test Categories
    • Laboratory Developed Tests
    • Next Generation Sequencing
    • Companion Diagnostics
    • CLIA Waivered Tests

Request Invite

WE GUARANTEE 100% PRIVACY, YOUR INFORMATION WILL NOT BE SHARED

Audience

75 Attendees

All attendees come directly from laboratories and diagnostic companies

Distinguished Presenters

Speaker recruitment in process

Networking

Networking time is built into the agenda to allow industry peers to connect and exchange ideas

Open Dialogue and Group Share

Each presentation is followed by 10-15 minutes of open dialogue for questions and exchange of best practices

Share This